Judge Denies SAM’s Temporary Restraining Order; CBD Pilot Program Launches
CBD pilot programs represent controlled opportunities to generate real-world safety and efficacy data under regulatory oversight. A judge has denied SAM's request for a temporary restraining order, allowing the CBD pilot program to proceed. These…
High Tide Subsidiary NuLeaf Naturals Pursues Medicare CBD Pilot Program
Medicare CBD insurance coverage is gaining attention as NuLeaf Naturals pursues participation in a new pilot program. This development could transform access to CBD for millions of older adults. The pilot represents a potential shift in federal insurance…
Bridging the Regulatory Chasm in Investigator‐Initiated Cannabis Research
Investigator initiated cannabis research barriers limit clinical studies and evidence-based medicine. Regulatory challenges impede rigorous cannabis research needed for informed decisions. Understanding these barriers is key to advancing cannabis…
Nonswallowed Kratom-Derived Products: Unlawful Dietary Supplements That Endanger Public Health.
Kratom regulatory safety is critical as non-oral kratom products bypass FDA oversight and violate dietary supplement laws. These unlawful formulations may endanger public health due to unknown safety profiles. Clinicians should be aware of these risks…
Understanding Cannabis Cash Management and Banking Challenges
Cannabis cash management is a critical issue due to banking restrictions that force cannabis businesses into cash-heavy operations. These challenges create supply chain vulnerabilities affecting product quality and patient safety. Understanding cannabis…